Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Oncology and Cancer Research
Metadata
Title
AKT1 and AKT2 promote malignant transformation in human brain glioma LN229 cells
Authors
Jian Zou
Kun Wang
Lei Han
An-ling Zhang
Zhen-dong Shi
Pei-yu Pu
Chun-sheng Kang
Publication date
01-09-2011
Publisher
Tianjin Medical University Cancer Institute and Hospital
Published in
Clinical Oncology and Cancer Research / Issue 3/2011
Print ISSN: 1674-5361
Electronic ISSN: 1868-324X
DOI
https://doi.org/10.1007/s11805-011-0573-9

Other articles of this Issue 3/2011

Clinical Oncology and Cancer Research 3/2011 Go to the issue

OriginalPaper

A meta-analysis of ginsenoside Rg3 for non-small cell lung cancer

OriginalPaper

Neurotrophic effect of bone marrow stromal cells on proliferation and committed differentiation of ventral mesencephalic precursors

OriginalPaper

Interaction between colon cancer cells and human liver sinusoidal endothelial cells promotes liver metastasis of tumor cells

OriginalPaper

Gemcitabine and docetaxel as a second-line treatment in advanced soft tissue sarcomas

OriginalPaper

Low-grade and high-grade invasive ductal carcinomas of the breast follow divergent routes of progression

OriginalPaper

Clinical efficacy of super-selective renal artery embolization for rupture of renal angiomyolipoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits